HOW WE'RE TACKLING LIVER DISEASE
Learn about the approaches we’re taking to develop new classes of medicines.
PRESS RELEASES
December 13, 2018
Jeff Jonker Joins Ambys Medicines as President and CEO
August 8, 2018
Ambys Medicines Launches with $140 Million to Pioneer Regenerative Medicine Therapies for Serious Liver Diseases
